Dr. Laura D’Ignazio is Head of Commercial Excellence & Engagement at MaxWell Biosystems AG. She earned her PhD at the University of Dundee and completed her postdoctoral training at the Lieber Institute for Brain Development, where she worked on X-linked Dystonia-Parkinsonism (XDP) and developed the first ventral-forebrain organoid model of the disease. Trained as molecular biologist, she brings hands-on experience in stem cells, neural organoid models, and neuroscience. In her current role, Laura drives user success through commercial excellence, engagement, and community building, helping researchers translate high-density microelectrode array (HD-MEA) data into scientific impact. Her interests include human iPSC-derived neural models, and phenotyping and screening workflows.